Medigene AG buy MoneyMoney
Start price
05.09.17
/
50%
€13.67
Target price
24.01.18
€17.00
Performance (%)
25.09%
End price
24.01.18
€17.10
Summary
This prediction ended on 24.01.18 with a price of €17.10. The BUY prediction by MoneyMoney finished with a performance of 25.09%. MoneyMoney has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Medigene AG | - | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% | 68.786% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% | 100.066% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% | 43.024% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% | 63.222% |
According to MoneyMoney what are the pros and cons of Medigene AG for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Significant cyclical dependencies
Comments by MoneyMoney for this prediction
In the thread Medigene AG diskutieren
Medigene
Übernahmefantasie bei den Biotech - Aktien ...
Stopped prediction by MoneyMoney for Medigene AG
Medigene AG
Start price
Target price
Perf. (%)
€3.79
22.02.22
22.02.22
€4.00
22.02.23
22.02.23
-45.05%
23.02.23
23.02.23
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Medigene AG
Start price
Target price
Perf. (%)
€14.12
09.04.18
09.04.18
€20.00
18.11.19
18.11.19
-58.75%
18.11.19
18.11.19
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Medigene AG
Start price
Target price
Perf. (%)
€8.96
10.01.16
10.01.16
€13.00
28.12.16
28.12.16
33.93%
28.12.16
28.12.16
Could be worthwhile Investment >10% per year
Significant cyclical dependencies